- Report
- July 2023
- 84 Pages
Global
From €3500EUR$3,929USD£3,035GBP
- Report
- September 2022
- 95 Pages
Global
From €3500EUR$3,929USD£3,035GBP
- Report
- March 2025
- 79 Pages
Global
From €3500EUR$3,929USD£3,035GBP
- Report
- January 2025
- 85 Pages
Global
From €3500EUR$3,929USD£3,035GBP
- Report
- March 2024
- 95 Pages
Global
From €3500EUR$3,929USD£3,035GBP
- Report
- February 2024
- 112 Pages
Global
From €3500EUR$3,929USD£3,035GBP
- Report
- August 2023
- 72 Pages
Global
From €3500EUR$3,929USD£3,035GBP
- Report
- January 2025
- 132 Pages
Global
From €907EUR$950USD£760GBP
The Adult Vaccine market is a segment of the larger Vaccine market, which focuses on providing immunizations to adults. Vaccines are used to protect adults from a variety of diseases, including influenza, hepatitis, and human papillomavirus. Vaccines are typically administered in a series of doses, and may require booster shots to maintain immunity. Vaccines are typically administered by healthcare professionals in a clinical setting, but some vaccines may be self-administered.
The Adult Vaccine market is highly competitive, with a variety of companies offering a range of products. Major players in the market include Merck & Co., GlaxoSmithKline, Sanofi, Pfizer, and Johnson & Johnson. These companies offer a range of vaccines, including influenza, hepatitis, and human papillomavirus vaccines. Additionally, some companies offer combination vaccines, which provide protection against multiple diseases in a single dose. Show Less Read more